Abstract Objectives: This study aims to evaluate the results and complications of surgical arterial revascularisation of the upper limb for treatment of chronic ischaemia using infrabrachial bypass. Results of limb salvage and follow-up with graft patency are analysed. Design: This study is a retrospective analysis of 23 patients affected by chronic upper limb ischaemia and treated by surgical bypass. Materials and methods: We retrospectively analysed 23 patients with upper limb ischaemia treated between January 1998 and January 2008, by means of bypass graft revascularisation. After surgical revascularisation, eight patients (35%) with digital gangrene underwent minor amputations during the same surgical session, or within the following few days. Postoperatively, patients were followed up at regular intervals of 1, 3 and 6 months, and every 6 months thereafter, both clinically and with a duplex ultrasound scan. Results: The mean 34 months' follow-up was 96% complete. Life table analysis revealed a primary patency of 82.6% and secondary patency of 91.3%. Limb salvage was 100%.
Introduction
Arterial reconstruction for the treatment of chronic upper limb ischaemia is infrequently performed in a vascular surgical practice. Upper limb ischaemia requiring surgical intervention accounts for 4% of all vascular surgical procedures. 1, 2 In the upper limb, it is more common to have emboli, trauma or thromboangiitis obliterans than to have chronic occlusive disease. 3 The increased survival of patients with chronic renal failure has led to a considerable increase in cases of upper limb critical ischaemia for which medical therapy and/or endovascular treatment have their limits and open surgery proves to be decisive. 4 In the literature, results of bypass in the upper limb are quite satisfying, with a reported patency rate of 60e90% at 2e years. 5, 6 We report our experience with arterial revascularisation of the upper limb for treatment of chronic ischaemia using infrabrachial bypass. Results of limb salvage and follow-up evaluation of graft patency are analysed.
Methods
Data that were prospectively entered into the registry of our vascular unit were analysed. We retrospectively analysed 23 patients with upper limb ischaemia treated between 1998 and 2008 by means of bypass graft revascularisation.
Patients treated by thrombo-embolectomy, patch angioplasty and direct suture for acute trauma were excluded. Indications for bypass grafts included: exercise intolerance, rest pain and tissue loss. All patients underwent preoperative evaluation with duplex ultrasound mapping to locate inflow and outflow sites for arterial revascularisation and to locate a suitable venous conduit (saphenous and arm veins).
Patients found to have arterial calcification preventing a correct ultrasound examination underwent preoperative angiography. After surgical revascularisation, patients with digital gangrene underwent debridement. This was performed in the same surgical session or during the subsequent few days.
Postoperative treatment included low-molecular-weight heparin (LMWH) treatment for 1 month, followed by antiplatelet medication alone. This was treated using aspirin, unless the patient was already on other anti-platelet medication (i.e., clopidogrel and ticlopidine).
Postoperatively, patients were followed up at regular intervals at 1, 3 and 6 months, and every 6 months thereafter. Graft patency was clinically evaluated by the presence of a palpable pulse and by duplex ultrasound. All data were prospectively entered at the time of treatment into a vascular registry (Microsoft â Access â and Excel â , Redmond, WA, USA), and the registry updated periodically with patient follow-up information. Data included demographics, indications for surgery, co-morbid conditions, specific operative details, complications and outcomes. A retrospective query of the database and chart reviews were done for this study. 
Results
From January 1998 to January 2008, 23 bypasses were performed on the brachial or infrabrachial artery in 23 patients. The mean age was 58 years (range, 19e76 years), with 13 male and 10 female patients (43.4%).
Concomitant diseases included: coronary artery disease in five (21.7%) patients, hypertension in six (26%), end-stage renal disease in nine (39%), diabetes in 11 (47.8%) and atrial fibrillation in two patients (8.6%) ( Table 1) .
Indications for bypass included exercise intolerance in four patients (17%), rest pain in nine (39%) and tissue loss in 10 (44%) ( Table 2) .
Five patients (22%) were scheduled for surgery after a previous endovascular procedure.
Angioplasty without stent implantation was previously performed on the brachial artery in one patient, on the radial artery in three and on the ulnar artery in one; with restenosis in three patients and occlusion in the other two patients. The mean time from the endovascular procedure to surgical revascularisation was 32 days (range: 26e40 days).
The aetiology of ischaemia was atherosclerosis in 17 patients (74%), complications of iatrogenic trauma in four patients (17.4%) and chronic ischaemia after embolic events in two patients (8.6%).
The brachial artery was used as the inflow source in 14 patients (60.8%), the axillary in two (8.6%), the radial artery in two (8.6%), the subclavian in four (17.4%) and the common carotid artery in one patient (4.3%).
Outflow arterial targets were: the brachial artery in seven patients (30.4%), the radial artery in 10 (43.4%), the ulnar artery in three (13%) and the deep palmar arch in three patients (13%).
Biological conduits were used in all patients except one. The conduits used were: the great saphenous vein (GSV) in 16 (70%) cases, an arm vein in three (13%), the bovine mesenteric vein (BMV) (Hancock Jaffe Laboratories, CA, USA) in three (13%) and polytetrafluoroethylene (PTFE) (W.L. Gore & Associates, Inc. Flagstaff, AZ, USA) in one case (4%) ( Table 3) .
Intra-operative angiography was performed with standard contrast agents in two patients (9%) with extensive arterial calcification. Preoperative duplex ultrasound was used in all of the other 21 patients (91%).
There were no perioperative deaths, no perioperative cardiac complications, no postoperative wound infection or limb loss and no incidence of postoperative pulmonary or renal failure in this series of upper limb bypass patients. Minor amputations were performed during the same surgical session for eight patients (35%) with digital gangrene. For three other patients (13%), minor lesion debridements were performed 2e3 days after revascularisation. The mean length of postoperative hospitalisation was 6 days (range: 4e7 days). The mean 34 months' follow-up was 96% complete, with one patient lost at 18 months (Table 3) . Life table analysis revealed a primary patency of 82.6% (standard error (SE) 10.02; 95% confidence interval (CI) (75.05e114.33)) and a secondary patency of 91.3% (SE 8.6%; 95% CI (89.24e 120.84)). Limb salvage was 100% (Fig. 1) .
During the follow-up period, four patients sustained graft occlusion:
(1) The first patient was a 38-year-old patient with a heavy history of drug abuse and previous arterial injection of heroin. He had chronic upper limb ischaemia, with severe arterial disease. He was revascularised using GSV. Occlusion after 7 days was unresponsive to further surgical management (Table 3 , patient 5). (2) The second patient was 76 years old with peripheral lower limb arterial disease and ischaemic heart disease. He was revascularised using a PTFE graft (6 mm in diameter, 18 cm in length) due to the lack of autogenous venous conduits and the unavailability of BMV or other biological substitutes in our institution at that time. Bypass occlusion after 30 days was successfully treated by thrombectomy. The bypass was patent at the 24-month follow-up control (Table 3 , patient 10). (3) The third patient was a 58-year-old man with end-stage renal disease on chronic haemodialysis, with previous lower limb revascularisation. He was revascularised using a BMV prosthesis (6 mm in diameter, 12 cm in length) due to lack of autogenous venous conduits. He had bypass occlusion 15 days after surgery, successfully treated by thrombectomy. The bypass was still open at the 36-month follow-up control (Table 3, patient 14) . (4) The fourth patient was a 37-year-old woman affected by type 1 diabetes and thrombophilia (factor V disease). She had occlusion of a brachial to ulnar bypass in the cephalic vein, 3 months after surgery. Before surgery she suffered griffinclaw hand and distal necrosis. After surgery, she had improvements in her symptoms and in wound healing after debridement. This improvement remained stable even after bypass closure. The patient is regularly followed up in our outpatient clinic, 12 months after surgery. She had prostacyclin treatment and enjoys a better motility status, with no further tissue loss (Table 3 , patient 22).
Discussion
Upper limb arterial revascularisation is not a frequently performed operation, accounting for approximately 4% of all vascular surgical procedures. 1, 2 This type of surgical treatment was first reported by Garret in 1965. 7 Since then, only a few other studies have reported on this treatment, and usually on small numbers of patients (Table 4) .
As noted also by Roddy et al. 8 and by Hughes, 9 unique demographic differences exist between upper and lower limb bypass populations. Patients with upper limb reconstruction typically present at a relatively early age (mean age of 58 in our study).
In our series of patients, the aetiology was atherosclerosis in 17 patients (74%), of which nine (39%) had concomitant end-stage renal disease. In those patients with end-stage renal disease, distal anastomoses were performed on very calcific and hard to handle ulnar and radial arteries. Clamping of those arteries was achieved using a distal manual clamp, or using an intra-arterial shunt, as previously described by our group. 10 Duplex ultrasound can be used in preoperative evaluation, as previously reported in other studies, due to the ability to locate a complete map of vessels in 89% of the cases. 11 In fact, in our series of patients we used duplex ultrasound scan in all the patients, except for two (8.6%) with end-stage renal disease. In those two cases, we used arteriography with standard contrast agents due to extreme arterial calcification, making useless the duplex ultrasound scan. For the same reason, it was necessary to perform a post-procedure arteriography.
The indication for surgery in our series was tissue loss for 44% of the cases. This specific indication has been more frequent than in other reported series. Roddy et al., 8 in their study, performed bypass grafts in patients with exertional arm pain in 30%, with rest pain in 57% and with tissue loss in 13% of patients. Hughes et al. 9 performed bypass grafts in patients with exertional arm pain in 55%, with rest pain in 30%, and with tissue loss in 3% of patients. This difference in indication for surgery is probably due to the fact that, in our institution, we usually treat patients with exertional arm pain using infusional vasoactive therapy for remission of symptoms, while surgical treatment is used for more severe conditions. In the presence of finger gangrene (44% of patients), we preferred to revascularise the arm arteries distally at the wrist level. In three cases, the distal anastomosis was completed on the deep palmar arch. The rationale of this strategy is to increase collateral circulation as close as possible to the necrotic area, with the aim of improving wound healing. Usually arm involvement is a consequence of extremely diffuse arterial disease.
Regarding the surgical technique, we believe that an appropriate conduit is critical for the success of the revascularisation. We used GSV in 16 patients. In patients with lower limb artery disease, when GSV was previously used for leg revascularisation, other conduits had to be chosen. The cephalic and the basilic veins represent an alternative. However, their use may carry some technical difficulties because of the presence of ectasia or lesions from previous infusional therapy in need of repair. With the aim of having better exposure during vein harvesting, we usually use a complete incision of the forearm. This technique is more invasive than the 'bridge cutaneous procedure'; however, we believe it may help to reduce vein injuries during harvesting.
In three patients (13%) affected by end-stage renal disease BMV was used, due to the absence of suitable In another patient, we used a PTFE prosthesis. This patient had graft thrombosis, necessitating further surgery.
Endovascular treatment is often proposed for chronic limb ischaemia. Concerning its role in the distal upper limbs, we should emphasise that five of the 23 patients had a previous angioplasty without good results.
Results of endovascular treatment on the distal upper limbs are still controversial.
There are not, at the moment, any large reported series with a long follow-up on the endovascular treatment of radial or ulnar arterial chronic ischaemic disease. At the present time, there are only case reports or small case series on endovascular treatment of this district. 12, 13 We think that endovascular techniques in the subclavian district can be useful in the treatment of proximal segments, whereas for distal segments further investigations are needed. This is in line with a recent report showing that endovascular treatment for cases of chronic ischaemia in the upper limb was associated with more complications as compared with an open surgical approach. 14 In patients with upper limb ischaemia, a cervico-dorsal sympathectomy is often proposed to heal toe ulcers, alone or in addition to a bypass. We do not have personal experience with this surgical approach. However, we believe this could be useful when associated with revascularisation for upper limb ischaemia. Both the traditional open sympathectomy and minimally invasive endoscopic transthoracic techniques have been used. 15 However, it should be considered that complications have been reported with dorsal sympathectomy. The most frequent complications are represented by Horner's syndrome, pneumothorax and haemothorax. More serious cardiovascular complications have been reported as well, 16 especially after bilateral treatment. For this reason it has been suggested that patients should be carefully questioned concerning possible vagal symptoms before undertaking cervico-dorsal sympathectomy. 
Conclusions
In conclusion, surgery for upper limb chronic ischaemia is an infrequent treatment. Endovascular treatment of the upper limb distal district has not been widely reported in the literature. Nevertheless, in our experience, endovascular procedures have not produced good results. We believe bypass surgery represents a valid treatment in this clinical setting, both for limb salvage and for relief of symptoms.
